Literature DB >> 9726612

Unilateral thoracoscopic reduction pneumoplasty for asymmetric emphysema.

T C Mineo1, E Pompeo, G Simonetti, A F Sabato, F Turani, P Rogliani, F De Padova, I Nofroni.   

Abstract

OBJECTIVE: We prospectively analyzed the surgical and functional results of unilateral thoracoscopic reduction pneumoplasty which we performed by choice in patients with asymmetric emphysema.
METHODS: Between October 1995 and June 1997, 119 emphysematous patients were examined and 34 were operated upon. Among these, 14 selected patients with asymmetric distribution of emphysema in the lungs underwent unilateral reduction pneumoplasty (ten right, and four left). There were 13 males and one female, with a mean age of 62 years. Eligibility criteria included bullous and non-bullous end-stage emphysema with severe limitation to daily activity.
RESULTS: No patient required conversion to thoracotomy. Mean operative time ranged between 70 and 240 min with a mean of 103 min. There was no postoperative mortality but five patients developed one or more complications: five prolonged air leaks (>7 days); two pulmonary infections; one empyema. No patient required postoperative mechanical ventilation. Median hospital stay was 8 days. At the 3-month follow-up the mean FEV1 increased from 0.8 l to 1.2 l (P < 0.001). Mean FVC increased from 2.6 l to 2.9 l (P < 0.001). The Medical Research Council dyspnea score decreased from a mean of 3.2 to 1.8 (P < 0.001).
CONCLUSIONS: Asymmetric distribution is a frequent finding in patients with severe emphysema. Unilateral thoracoscopic reduction pneumoplasty may represent an ideal approach in this selected group of patients.

Entities:  

Mesh:

Year:  1998        PMID: 9726612     DOI: 10.1016/s1010-7940(98)00134-1

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  1 in total

Review 1.  The complex care of severe emphysema: role of awake lung volume reduction surgery.

Authors:  Eugenio Pompeo; Paola Rogliani; Leonardo Palombi; Augusto Orlandi; Benedetto Cristino; Mario Dauri
Journal:  Ann Transl Med       Date:  2015-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.